The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Increased β-Cell Secretory Capacity as Mechanism for Islet Adaptation to Nicotinic Acid-Induced Insulin Resistance
Abstract
To determine whether prolonged nicotinic acid (NA) administration produces insulin resistance and, if so, how the normal pancreatic islet adapts to prolonged insulin resistance, we administered incremental doses of NA to 11 normal men for 2 wk, ending at 2 g/day. Insulin sensitivity was measured with Bergman's minimal model. Islet function was evaluated by measurement of acute insulin (AIR) and glucagon (AGR) responses to arginine at three glucose levels. Insulin resistance was demonstrated and quantified by a marked drop in the insulin sensitivity index (S1) from 6.72 ± 0.77 to 2.47 ± 0.36 × 10−5 min−1/pM (P < .0001) and resulted in a doubling of basal immunoreactive insulin levels (from 75 ± 7 to 157 ± 21 pM, P < .001) with no change in fasting glucose (5.5 ± 0.1 vs. 5.7 ± 0.1 mM). Proinsulin levels also increased (from 9 ± 1 to 15 ± 2 pM, P < .005), but the ratio of proinsulin to immunoreactive insulin did not change (12.7 ± 1.9 vs. 10.3 ± 1.9%). β-Cell changes were characterized by increases in the AIR to glucose (from 548 ± 157 to 829 ± 157 pM, P < .005) and in the AIR to arginine at the fasting glucose level (from 431 ± 54 to 788 ± 164 pM, P < .05). At the maximal hyperglycemia level the AIR to arginine represents β-cell secretory capacity, and this increased with administration of NA (from 2062 ± 267 to 2630 ± 363 pM, P < .05). From the AIRs to arginine an estimate of the glucose level giving half-maximal AIR to arginine can be calculated. This measure did not increase (10.0 ± 0.5 vs. 9.6 ± 0.9 mM). The AGRs to argininewere reduced at all glucose levels during NA administration. Thus, the pancreatic islet adapts to the prolonged insulin resistance induced by NA. This adaptation comprises a combination of increased insulin secretion and reduced glucagon secretion. The changes in insulin secretion can be entirely explained by an increase in the secretory capacity of the β-cell.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while insulin secretion increased in response to nicotinic acid-induced insulin resistance, this compensation was incomplete.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [28]
In the citing paper
“the variation in insulin release that occurs in response to differences in insulin sensitivity is the result of changes in the secretory capacity of the beta cell and not its sensitivity to glucose [28, 54] (Fig. 2B).”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [28]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Self-citationKahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
Self-citationAntiretroviral Treatment for Adult HIV Infection in 2002
Yéni, P., Hammer, S. M., Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B., Hirsch, M., Jacobsen, D. M., Katzenstein, D. A., et al. (2002) · JAMA · doi:10.1001/jama.288.2.222 · Cited by 710
The Importance of -Cell Failure in the Development and Progression of Type 2 Diabetes
Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 710
Self-citationDubé, M. P., Stein, J. H., Aberg, J. A., Fichtenbaum, C. J., Gerber, J. G., Tashima, K. T., Henry, W. K., Currier, J. S., Sprecher, D. L., & Glesby, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/378131 · Cited by 578
Elam, M. B., Hunninghake, D. B., Davis, K. B., Garg, R., Johnson, C. W., Egan, D., Kostis, J. B., Sheps, D. S., Brinton, E. A., & for the ASTEROID Investigators (2000) · JAMA · doi:10.1001/jama.284.10.1263 · Cited by 509
McKenney, J. M. (1994) · JAMA · doi:10.1001/jama.1994.03510330050033 · Cited by 303
Nicotinic Acid as Therapy for Dyslipidemia in Non—Insulin-Dependent Diabetes Mellitus
Garg, A. (1990) · JAMA · doi:10.1001/jama.1990.03450060069031 · Cited by 286
Safety considerations with niacin therapy
Guyton, J. R., & Bays, H. E. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.018 · Cited by 269
Kahn, S. E., Prigeon, R. L., Schwartz, R. S., Fujimoto, W. Y., Knopp, R. H., Brunzell, J. D., & Porte, D. (2001) · Journal of Nutrition · doi:10.1093/jn/131.2.354s · Cited by 240
Self-citationRøder, M. E., Porte, D., Schwartz, R. S., & Kahn, S. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4544 · Cited by 207
Self-citationDrug-Induced Hyperglycaemia and Diabetes
Fathallah, N., Slim, R., Larif, S., Hmouda, H., & Salem, C. B. (2015) · Drug Safety · doi:10.1007/s40264-015-0339-z · Cited by 215
Hyperlipidemia and Diabetes Mellitus
O’Brien, T., Nguyen, T. T., & Zimmerman, B. R. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.10.969 · Cited by 203
Mayer, K. H., Dubé, M. P., Sprecher, D. L., Henry, W. K., Aberg, J. A., Torriani, F. J., Hodis, H. N., Schouten, J., Levin, J., Myers, G. L., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/317429 · Cited by 196
Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes
Weir, G. C., Gaglia, J. L., & Bonner‐Weir, S. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30022-x · Cited by 196
Fabbrini, E., Mohammed, B. S., Korenblat, K. M., Magkos, F., McCrea, J., Patterson, B. W., & Klein, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2622 · Cited by 192
Adaptation of β-cell mass to substrate oversupply: enhanced function with normal gene expression
Steil, G. M., Trivedi, N., Jonas, J., Hasenkamp, W. M., Sharma, A., Bonner‐Weir, S., & Weir, G. C. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e788 · Cited by 162
Swinburn, B. A., Boyce, V., Bergman, R. N., Howard, B. V., & Bogardus, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-156 · Cited by 154
Self-citationChanges in Insulin Sensitivity, Secretion and Glucose Effectiveness During Menstrual Cycle
Pulido, J. M. E., & Salazar, M. A. (1999) · Archives of Medical Research · doi:10.1016/s0188-0128(98)00008-6 · Cited by 148
Niacin therapy in atherosclerosis
Meyers, C. D., Kamanna, V. S., & Kashyap, M. L. (2005) · Current Opinion in Internal Medicine · doi:10.1097/00132980-200502000-00005 · Cited by 139
Insulin resistance in type 1 diabetes
Greenbaum, C. J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.291 · Cited by 133
Pancreatic beta-cell loss and preservation in type 2 diabetes
Buchanan, T. A. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80241-2 · Cited by 132
Åhrén, B., Simonsson, E., Scheurink, A. J. W., Mulder, H., Myrsén-Axcrona, U., & Sundler, F. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90175-x · Cited by 129
Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART
Calza, L., Manfredi, R., & Chiodo, F. (2003) · AIDS · doi:10.1097/00002030-200304110-00010 · Cited by 120
Kannt, A., Pfenninger, A., Teichert, L., Tönjes, A., Dietrich, A., Schön, M. R., Klöting, N., & Blüher, M. (2015) · Diabetologia · doi:10.1007/s00125-014-3490-7 · Cited by 118
Effects of Niacin on Glucose Control in Patients With Dyslipidemia
Goldberg, R. B., & Jacobson, T. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.4.470 · Cited by 112
Poynten, A. M., Gan, S. K., Kriketos, A. D., O’Sullivan, A., Kelly, J. J., Ellis, B. A., Chisholm, D. J., & Campbell, L. V. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00030-1 · Cited by 104
Larsson, H. E., & Åhrén, B. (1998) · Diabetologia · doi:10.1007/s001250050986 · Cited by 103
Impaired β-Cell Function in Human Aging: Response to Nicotinic Acid-Induced Insulin Resistance
Chang, A. M., Smith, M. J., Gałecki, A. T., Bloem, C. J., & Halter, J. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0913 · Cited by 103
The benefits of niacin in atherosclerosis
Tavintharan, S., & Kashyap, M. L. (2001) · Current Atherosclerosis Reports · doi:10.1007/s11883-001-0014-y · Cited by 100
Hyperlipidemia in diabetes mellitus
Dunn, F. L. (1990) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610060103 · Cited by 99
Longevity of human islet α ‐ and β ‐cells
Cnop, M., Igoillo‐Esteve, M., Hughes, S. J., Walker, J. N., Cnop, I., & Clark, A. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01443.x · Cited by 100
Kahn, S. E., Klaff, L. J., Schwartz, M. W., Beard, J. C., Bergman, R. N., Taborsky, G. J., & Porte, D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-994 · Cited by 91
Self-citationMatsumoto, K., Yamasaki, H., Akazawa, S., Sakamaki, H., Ishibashi, M., Abiru, N., Uotani, S., Matsuo, H., Yamaguchi, Y., Tokuyama, K., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.7.8675587 · Cited by 91
Seaquist, E. R., Kahn, S. E., CLARK, P. M. S., Hales, C. N., Porte, D., & Robertson, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118435 · Cited by 89
Self-citationIslet adaptation to insulin resistance: mechanisms and implications for intervention
Åhrén, B., & Pacini, G. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00361.x · Cited by 86
Remick, J. S., WEINTRAUB, H. S., Setton, R. A., Offenbacher, J., Fisher, E. A. A., & Schwartzbard, A. Z. (2008) · Cardiology in Review · doi:10.1097/crd.0b013e31816b43d3 · Cited by 83
Nicotinamide overload may play a role in the developmentof type 2 diabetes
Zhou, S., Li, D., Sun, W., Guo, M., Lun, Y., Zhou, Y., Xiao, F., Li-xin, J., Sun, S., Zhang, L.-B., et al. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5674 · Cited by 80
Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease
Després, J., Lemieux, I., & Robins, S. J. (2004) · Drugs · doi:10.2165/00003495-200464190-00003 · Cited by 76
Kaiyala, K., Prigeon, R., Kahn, S., Woods, S. C., Porte, D., & Schwartz, M. (1999) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.4.e659 · Cited by 72
Self-citationDyslipidemia in Non-Insulin-Dependent Diabetes Mellitus
Howard, B. V., & Howard, W. J. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-263 · Cited by 76
Diet-Induced Weight Loss Is Associated with an Improvement in β-Cell Function in Older Men
Utzschneider, K. M., Carr, D. B., Barsness, S. M., Kahn, S. E., & Schwartz, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031827 · Cited by 73
Self-citationLarsson, H., & Ahrén, B. (1999) · Diabetologia · doi:10.1007/s001250051251 · Cited by 73
Use of Fibrates in the Management of Hyperlipidemia in HIV-Infected Patients Receiving HAART
Calza, L., Manfredi, R., & Chiodo, F. (2002) · Infection · doi:10.1007/s15010-001-2052-3 · Cited by 72
Cheng, Q., Law, P. K., de Gasparo, M., & Leung, P. S. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.142703 · Cited by 73
Meyers, C. D., Carr, M. C., Park, S., & Brunzell, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-12-200312160-00009 · Cited by 71
Niacin revisited: Clinical observations on an important but underutilized drug
Henkin, Y., Oberman, A., Hurst, D. C., & Segrest, J. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90122-e · Cited by 72
Zhou, S., Li, D., Zhou, Y., Sun, W., & Liu, Q. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-746 · Cited by 68
Prigeon, R., Kahn, S. E., & Porte, D. (1998) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.83.3.4641 · Cited by 79
Self-citationGentile, S., Turco, S., Guarino, G., Sasso, F. C., Amodio, M., Magliano, P. L., Salvatore, T., Corigliano, G., Agrusta, M., SIMONE, G. D., et al. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00106.x · Cited by 66
Åhrén, B., & Pacini, G. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.4.e701 · Cited by 66
Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology.
Bergman, R. N. (2002) · PubMed · Cited by 64
Self-citationSafety Considerations and Potential Interactions of Vitamins: Should Vitamins Be Considered Drugs?
Rogovik, A. L., Vohra, S., & Goldman, R. D. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m238 · Cited by 65
Effects of nicotinic acid on insulin sensitivity and blood pressure in healthy subjects
Kelly, J., Lawson, J. A., Campbell, L., Storlien, L., Jenkins, A. B., Whitworth, J. E., & O'Sullivan, A. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001099 · Cited by 64
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures
Kahn, S. E., Chen, Y., Esser, N., Taylor, A. J., van Raalte, D. H., Zraika, S., & Verchere, C. B. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab021 · Cited by 75
Self-citationNiacin in HIV-Infected Individuals with Hyperlipidemia Receiving Potent Antiretroviral Therapy
Gerber, M. T., Mondy, K. E., Yarasheski, K. E., Drechsler, H., Claxton, S., Stoneman, J. S., DeMarco, D., Powderly, W. G., & Tebas, P. (2004) · Clinical Infectious Diseases · doi:10.1086/422144 · Cited by 63
Methods and Models for Metabolic Assessment in Mice
Pacini, G., Omar, B., & Åhrén, B. (2013) · Journal of Diabetes Research · doi:10.1155/2013/986906 · Cited by 64
The skin function: a factor of anti-metabolic syndrome
Zhou, S., Li, D., Zhou, Y., & Cao, J.-M. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-15 · Cited by 92
Larsson, H. E., & Ahr�n, B. (1996) · Diabetologia · doi:10.1007/bf00400660 · Cited by 60
An examination of β‐cell function measures and their potential use for estimating β‐cell mass
Kahn, S. E., Carr, D. B., Faulenbach, M. V., & Utzschneider, K. M. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00945.x · Cited by 59
Self-citationKahn, S. E., Larson, V., Schwartz, R. S., Beard, J. C., Cain, K. C., Fellingham, G. W., Stratton, J. R., Cerqueira, M., & Abrass, I. B. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.6.1592879 · Cited by 58
Self-citationInsulin, Neuropeptide Y, and Food Intake
Schwartz, M. W., Figlewicz, D. P., Woods, S. C., Porte, D., & Baskin, D. G. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb26206.x · Cited by 59
Self-citationIncreased β-Cell Workload Modulates Proinsulin-to-Insulin Ratio in Humans
Mezza, T., Ferraro, P. M., Sun, V. A., Moffa, S., CEFALO, C. M. A., Quero, G., Cinti, F., Sorice, G. P., Pontecorvi, A., Folli, F. B., et al. (2018) · Diabetes · doi:10.2337/db18-0279 · Cited by 57
Leahy, J. L., Bumbalo, L. M., & Chen, C. (1993) · Diabetologia · doi:10.1007/bf00400800 · Cited by 56
Meixner, L., Hoffman, J., Zwickl, B., Goldman, M. H., Whitely, K., Conrad, A., Fichtenbaum, C. J., Hyc, F., Spitz, T., Shaw, D. D., et al. (2006) · Antiviral Therapy · doi:10.1177/135965350601100802 · Cited by 55
Chronic niacin overload may be involved in the increased prevalence of obesity in US children
Li, D. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i19.2378 · Cited by 55
Human aging is associated with parallel reductions in insulin and amylin release
Dechenes, C. J., Verchere, C. B., Andrikopoulos, S., & Kahn, S. E. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e785 · Cited by 55
Self-citationSmith, S. A., Porter, L. E., Biswas, N., & Freed, M. I. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0705 · Cited by 54
Linke, A. H.-P., Sonnabend, M., Faßhauer, M., Höllriegel, R., Schuler, G. C., Niebauer, J., Stümvoll, M., & Blüher, M. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.11.026 · Cited by 53
Short-term K+deprivation provokes insulin resistance of cellular K+uptake revealed with the K+clamp
Choi, C. S., Thompson, C. B., Leong, P. K. K., McDonough, A. A., & Youn, J. H. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.1.f95 · Cited by 51
β-Cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia
Liu, Y. Q., Nevin, P. W., & Leahy, J. L. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.1.e68 · Cited by 51
Treatment of Diabetic Dyslipidemia
Garg, A. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00038-1 · Cited by 50
Røder, M., Schwartz, R. S., Prigeon, R., & Kahn, S. E. (2000) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.85.6.6635 · Cited by 61
Self-citationClore, J. N., Harris, P. A., Li, J., Azzam, A., Gill, R. S., Zuelzer, W. A., Rizzo, W. B., & Blackard, W. G. (2000) · Metabolism · doi:10.1016/s0026-0495(00)91455-0 · Cited by 49
Management of dyslipidemia in people with type 2 diabetes mellitus
Dunn, F. L. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9132-6 · Cited by 43
Dietary methyl-consuming compounds and metabolic syndrome
Zhou, S., Zhou, Y., Li, D., & Lun, Y. (2011) · Hypertension Research · doi:10.1038/hr.2011.133 · Cited by 44
HYPERGLYCEMIC CRISES IN DIABETES MELLITUS TYPE 2
Trence, D., & Hirsch, I. B. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70217-6 · Cited by 42
Best, J. D., & Neal, D. N. O. (2000) · Drugs · doi:10.2165/00003495-200059050-00006 · Cited by 41
McCulloch, D. K., Kahn, S. E., Schwartz, M. W., Koerker, D. J., & Palmer, J. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115145 · Cited by 41
Self-citationGrill, V., Johansson, B., Jalkanen, P., & Eriksson, U. J. (1991) · Diabetologia · doi:10.1007/bf00403173 · Cited by 41
Pharmacologic Treatment of Type 2 Diabetic Dyslipidemia
Moon, Y. S. K., & Kashyap, M. L. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.17.1692.52340 · Cited by 41
Severe Reversible Hyperglycemia as a Consequence of Niacin Therapy
Schwartz, M. L. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.17.2050 · Cited by 41
Self-citationCharles, M.-A. A., Eschw�ge, E., Grandmottet, P., Isnard, F., Cohen, J., Bensoussan, J.-L., Berche, H., Chapiro, O., Andr�, P., Vague, P., et al. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(200001/02)16:1 · Cited by 58
Alvarsson, M., & Grill, V. (1996) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519609088812 · Cited by 39
Interactions Between Glucose and FFA Metabolism in Man
Saloranta, C., & Groop, L. (1996) · Diabetes/Metabolism Reviews · doi:10.1002/(sici)1099-0895(199603)12:1 · Cited by 37
Long-term cardiovascular risk with protease inhibitors and management of the dyslipidemia
Kannel, W. B., & Giordano, M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.06.025 · Cited by 37
Modeling Of Insulin Action In Vivo
Bergman, R. N., Steil, G. M., Bradley, D. C., & Watanabe, R. M. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004241 · Cited by 36
Self-citationKahn, S. E., Bergman, R. N., Schwartz, M. W., Taborsky, G. J., & Porte, D. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.262.4.e518 · Cited by 37
Self-citationThe Minimal Model of Glucose Regulation: A Biography
Bergman, R. N. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9019-8_1 · Cited by 41
Self-citationEpidemiology and Management of Antiretroviral-Associated Cardiovascular Disease
Chastain, D. B., Henderson, H. M., & Stover, K. R. (2015) · The Open AIDS Journal · doi:10.2174/1874613601509010023 · Cited by 32
EFFECTS OF CRYOPRESERVATION ON IN VITRO AND IN VIVO LONG-TERM FUNCTION OF HUMAN ISLETS1
Piemonti, L., Bertuzzi, F., Nano, R., Leone, B. E., Socci, C., Pozza, G., & Carlo, V. D. (1999) · Transplantation · doi:10.1097/00007890-199909150-00011 · Cited by 31
Teff, K. L., & Townsend, R. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032094 · Cited by 30
Choi, C. S., Lee, F. N., McDonough, A. A., & Youn, J. H. (2002) · Diabetes · doi:10.2337/diabetes.51.4.915 · Cited by 30
Wang, M., & Fotsch, C. H. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.010 · Cited by 30
Shih, K., Kwok, C., Hwu, C., Hsiao, L.-C., Li, S.-H., Liu, Y.-F., & Ho, L.-T. (1997) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(97)00039-9 · Cited by 29
Åhrén, B. (2008) · Diabetologia · doi:10.1007/s00125-008-0995-y · Cited by 31
Rasouli, N., Hale, T. C., Kahn, S. E., Spencer, H. J., & Elbein, S. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0048 · Cited by 29
Self-citationNiacin extended-release/ lovastatin: combination therapy for lipid disorders
Moon, Y. S., & Kashyap, M. L. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.12.1763 · Cited by 28
β‐cell deterioration – prospects for reversal or prevention
Finegood, D. T., & Topp, B. G. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00030.x · Cited by 28
Metadata
- Authors
- Kahn, S. E., Beard, J. C., Schwartz, M. W., Ward, W. K., Ding, H. L., Bergman, R. N., Taborsky, G. J., & Porte, D.
- Affiliations
- University of Southern California (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1989-05-01
- Volume
- 38
- Issue
- 5
- Pages
- 562-568
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W1979102029
- Cited by
- 181
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 2 · 2015: 7 · 2014: 2 · 2013: 5 · 2012: 6
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 12829, DK-17047)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- nicotinic acid, insulin resistance, acute insulin response, arginine stimulation, proinsulin, insulin sensitivity, hyperinsulinemic-euglycemic clamp, Bergman minimal model, islet function
- MeSH terms
- Adult, Blood Glucose, Epinephrine, Glucagon, Humans, Hydrocortisone, Injections, Intravenous, Insulin Resistance, Islets of Langerhans, Male, Nicotinic Acids, Norepinephrine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review